QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
LON:SN

Smith & Nephew - SN Share Forecast, Price & News

GBX 1,091.50
+19.50 (+1.82%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
1,074
1,095
50-Day Range
984.60
1,103.50
52-Week Range
959.20
1,357.50
Volume
2.20 million shs
Average Volume
343,671 shs
Market Capitalization
£9.50 billion
P/E Ratio
2,322.34
Dividend Yield
2.89%
Price Target
GBX 1,408.60

Smith & Nephew MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
29.1% Upside
GBX 1,408.60 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
£2.01 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.72 out of 5 stars

SN stock logo

About Smith & Nephew (LON:SN) Stock

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Receive SN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SN Stock News Headlines

Smith & Nephew (LON:SN) Stock Rating Reaffirmed by Berenberg Bank
GSK Taps Burberry Executive As CFO
Smith & Nephew Becomes Pharma Family Factor
Smith & Nephew plc (SN.L)
See More Headlines
Receive SN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SN Company Calendar

Ex-Dividend for 10/26 Dividend
9/29/2022
Dividend Payable
10/26/2022
Today
12/08/2022
Next Earnings (Estimated)
2/21/2023

Industry, Sector and Symbol

Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
18,369
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 1,408.60
High Stock Price Forecast
GBX 1,500
Low Stock Price Forecast
GBX 1,243
Forecasted Upside/Downside
+29.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£5.21 billion
Cash Flow
GBX 59.31 per share
Book Value
GBX 615.70 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.50 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Ms. Anne-Francoise Nesmes (Age 50)
    CFO & Exec. Director
    Comp: $1.71M
  • Dr. Deepak S. Nath Ph.D. (Age 49)
    CEO & Director
  • Mr. Paul Connolly (Age 54)
    Pres of Global Operations
  • Mr. Andrew Swift
    VP of Investor Relations
  • Ms. Helen Barraclough (Age 43)
    Group Gen. Counsel, Company Sec. & Director
  • Ms. Alison Parkes (Age 50)
    Chief Compliance Officer
  • Mr. Joe Metzger
    Sr. VP of Marketing Services & Communications
  • Ms. Elga Lohler (Age 54)
    Chief HR Officer
  • Mr. Philip G. Cowdy (Age 55)
    Chief Bus. Devel. & Corp. Affairs Officer
  • Mr. Bradley Cannon (Age 54)
    Pres of Orthopaedics, Sports Medicine & ENT and Americas













SN Stock - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SN shares.
View SN analyst ratings
or view top-rated stocks.

What is Smith & Nephew's stock price forecast for 2023?

5 Wall Street research analysts have issued 1 year price objectives for Smith & Nephew's stock. Their SN share price forecasts range from GBX 1,243 to GBX 1,500. On average, they expect the company's stock price to reach GBX 1,408.60 in the next twelve months. This suggests a possible upside of 29.1% from the stock's current price.
View analysts price targets for SN
or view top-rated stocks among Wall Street analysts.

How have SN shares performed in 2022?

Smith & Nephew's stock was trading at GBX 1,293.50 on January 1st, 2022. Since then, SN stock has decreased by 15.6% and is now trading at GBX 1,091.50.
View the best growth stocks for 2022 here
.

When is Smith & Nephew's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our SN earnings forecast
.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a dividend on Thursday, July 28th. Stockholders of record on Thursday, September 29th will be given a dividend of GBX 0.14 per share on Wednesday, October 26th. This represents a yield of 0.99%. The ex-dividend date of this dividend is Thursday, September 29th. The official announcement can be viewed at this link.
Read our dividend analysis for SN
.

Is Smith & Nephew a good dividend stock?

Smith & Nephew (LON:SN) pays an annual dividend of GBX 31 per share and currently has a dividend yield of 2.89%. The dividend payout ratio is 6,595.74%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for SN.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Imperial Brands (IMB), Smith & Nephew (SNN), Alexion Pharmaceuticals (ALXN), Barclays (BARC), GSK (GSK), Diageo (DGE), Standard Chartered (STAN), Unilever (ULVR), British American Tobacco (BATS) and BHP Group (BHP).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the London Stock Exchange (LON) under the ticker symbol "SN."

How do I buy shares of Smith & Nephew?

Shares of SN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Smith & Nephew's stock price today?

One share of SN stock can currently be purchased for approximately GBX 1,091.50.

How much money does Smith & Nephew make?

Smith & Nephew (LON:SN) has a market capitalization of £9.50 billion and generates £5.21 billion in revenue each year.

How many employees does Smith & Nephew have?

The company employs 18,369 workers across the globe.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The official website for the company is www.smith-nephew.com. The company can be reached via phone at +44-20-74017646.

This page (LON:SN) was last updated on 12/8/2022 by MarketBeat.com Staff